The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 590.00
Bid: 584.00
Ask: 589.00
Change: 12.00 (2.08%)
Spread: 5.00 (0.856%)
Open: 582.00
High: 590.00
Low: 581.00
Prev. Close: 578.00
BAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Merger Update

13 Feb 2013 16:07

RNS Number : 8298X
Britvic plc
13 February 2013
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

For Immediate Release

13 February 2013

A.G. BARR p.l.c. ("A.G. Barr") and Britvic plc ("Britvic")

All-share merger update: OFT decision

The Boards of A.G. Barr and Britvic note the announcement by the Office of Fair Trading (the "OFT") today of its decision to refer the merger of A.G. Barr and Britvic (the "Merger") to the Competition Commission.

Publication of the full text of the OFT's decision is awaited. A.G. Barr and Britvic will continue to work together and will make a further joint announcement following their combined review of the OFT's full decision.

As a result of the OFT's decision, condition 3(c) to the Merger (as set out in Part A of Part IV of the Scheme Document dated 5 December 2012) relating to UK merger control has not been satisfied and is now invoked by A.G. Barr. In accordance with its terms, the Merger has now lapsed and Britvic confirms that the Scheme will not proceed.

Under Rule 12.2 of the Takeover Code, the Offer Period in relation to Britvic has now ended and a competition reference period has now commenced.

Capitalised terms used but not defined in this announcement have the same meanings as set out in the Scheme Document dated 5 December 2012.

Enquiries

A.G. BARR p.l.c.

Roger White

Alex Short +44 (0) 1236 852 400

Rothschild (financial adviser to A.G. Barr)

Akeel Sachak

Stuart Vincent

Jessica Dale +44 (0) 207 280 5000

Investec Bank plc (broker to A.G. Barr)

Keith Anderson

David Anderson

Henry Reast +44 (0) 207 597 5970

College Hill (PR adviser to A.G. Barr)

Justine Warren

Matthew Smallwood +44 (0) 207 457 2020

Britvic plc

Gerald Corbett

John Gibney

Rupen Shah

Steve Nightingale +44 (0) 1442 284330

Citigroup Global Markets Limited

(joint financial adviser and joint broker to Britvic)

David Wormsley

Jan Skarbek

Andrew Seaton +44 (0) 207 986 4000

Nomura International plc

(joint financial adviser and joint broker to Britvic)

Nicholas Marren

Ed Matthews +44 (0) 207 521 2000

Brunswick (PR adviser to Britvic)

Mike Smith

Nick Cosgrove +44 (0) 207 404 5959

 

Rothschild, which is authorised and regulated in the United Kingdom by the FSA, is acting exclusively for A.G. Barr and for no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than A.G. Barr for providing the protections afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Investec Bank plc, which is authorised and regulated in the United Kingdom by the FSA, is acting as corporate broker to A.G. Barr and for no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than A.G. Barr for providing the protections afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Citigroup Global Markets Limited, which is authorised and regulated in the United Kingdom by the FSA, is acting exclusively for Britvic and for no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than Britvic for providing the protections afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Nomura International plc, which conducts its UK investment banking business as Nomura, is authorised and regulated in the United Kingdom by the FSA and is acting as joint broker and joint financial adviser to Britvic and for no-one else in connection with the matters set out in this announcement. Nomura will not be responsible to anyone other than Britvic for providing the protection afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Publication on website

A copy of this announcement will be made available, free of charge, subject to certain restrictions relating to persons resident in restricted jurisdictions, on Britvic's and A.G. Barr's websites at http://ir.britvic.comand www.agbarr.co.ukrespectively by no later than noon (London time) on the day following the date of this announcement. For the avoidance of doubt, the contents of those websites are not incorporated into and do not form part of this announcement.

You may request a hard copy of this announcement by contacting the Company Secretary of Britvic at company.secretariat@britvic.co.uk(or on +44(0)1442 284411) or by writing to Britvic plc, Breakspear Park, Breakspear Way, Hemel Hempstead, HP2 4TZ, or by contacting the Company Secretary of A.G. Barr at companysecretarialdepartment@agbarr.co.uk(or on +44(0)1236 852400) or by writing to A.G. BARR p.l.c., Westfield House, 4 Mollins Road, Cumbernauld, G68 9HD. You may also request that all future documents, announcements and information to be sent to you in relation to the Merger should be in hard copy form.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MERLLFIRFEIVLIV
Date   Source Headline
7th May 20249:06 amRNSDirector/PDMR Shareholding
23rd Apr 20249:17 amRNSAnnual Financial Report
15th Apr 20242:59 pmRNSDirector/PDMR Shareholding
9th Apr 20243:46 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 20243:36 pmRNSDirector/PDMR Shareholding
9th Apr 20241:05 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 202412:50 pmRNSDirector/PDMR Shareholding
5th Apr 20242:26 pmRNSDirector/PDMR Shareholding
2nd Apr 202411:15 amRNSDirector/PDMR Shareholding
28th Mar 202410:10 amRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSDirectorate changes announcement
26th Mar 20247:00 amRNSFinal Results
14th Mar 20243:01 pmRNSBusiness reorganisation
11th Mar 20248:39 amRNSDirector/PDMR Shareholding
27th Feb 20241:47 pmRNSHolding(s) in Company
8th Feb 20242:03 pmRNSDirector/PDMR Shareholding - Replacement
8th Feb 20241:51 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBoard succession announcement
1st Feb 20247:00 amRNSTrading Update
16th Jan 20247:00 amRNSNotice of Trading Update
9th Jan 20241:36 pmRNSDirector/PDMR Shareholding
14th Dec 20239:22 amRNSDirector Declaration
11th Dec 20239:47 amRNSDirector/PDMR Shareholding
17th Nov 202310:13 amRNSUpdate statement on 2023 AGM Voting Results
8th Nov 202310:45 amRNSDirector/PDMR Shareholding
3rd Nov 20233:44 pmRNSDirector/PDMR Shareholding
30th Oct 20233:10 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSAcquisition of tropical drinks brand Rio
10th Oct 20238:21 amRNSDirector/PDMR Shareholding
26th Sep 20237:00 amRNSInterim Results
11th Sep 20239:08 amRNSDirector/PDMR Shareholding
8th Aug 20232:07 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSBoard succession announcement
1st Aug 20237:00 amRNSTrading update for the 26 weeks ended 30 July 2023
10th Jul 202312:42 pmRNSDirector/PDMR Shareholding
14th Jun 20239:40 amRNSDirector/PDMR Shareholding
13th Jun 20239:24 amRNSDirector/PDMR Shareholding - Replacement
13th Jun 20238:59 amRNSDirector/PDMR Shareholding
13th Jun 20238:55 amRNSDirector/PDMR Shareholding
12th Jun 20233:59 pmRNSDirector/PDMR Shareholding
8th Jun 20231:02 pmRNSDirector/PDMR Shareholding
26th May 20231:57 pmRNSDirectorate Change
26th May 20231:55 pmRNSResult of AGM
10th May 20239:25 amRNSDirector/PDMR Shareholding
4th May 20239:22 amRNSDirector Declaration
25th Apr 20239:14 amRNSAnnual Financial Report / Notice of AGM
12th Apr 20233:31 pmRNSDirector/PDMR Shareholding
12th Apr 202311:23 amRNSDirector/PDMR Shareholding
11th Apr 202310:07 amRNSDirector/PDMR Shareholding
30th Mar 202310:24 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.